Market revenue in 2022 | USD 457.3 million |
Market revenue in 2030 | USD 980.6 million |
Growth rate | 10% (CAGR from 2022 to 2030) |
Largest segment | Artificial organ |
Fastest growing segment | Artificial bionics |
Historical data | 2018 - 2021 |
Base year | 2022 |
Forecast period | 2023 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Artificial Organ, Artificial bionics |
Key market players worldwide | Zimmer Biomet Holdings Inc, Boston Scientific Corp, Cochlear Ltd, Edwards Lifesciences Corp, Ekso Bionics Holdings Inc, Medtronic PLC, Symbotic Inc Ordinary Shares - Class A, Johnson & Johnson, Berlin Heart GmbH, SynCardia Systems |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to artificial organs and bionics market will help companies and investors design strategic landscapes.
Artificial organ was the largest segment with a revenue share of 70.28% in 2022. Horizon Databook has segmented the Brazil artificial organs and bionics market based on artificial organ, artificial bionics covering the revenue growth of each sub-segment from 2018 to 2030.
Brazil accounts for a major share in Latin America’s market, as the country has the largest healthcare market in the region, with a healthcare expenditure of 9.2% of its GDP on healthcare in 2017. Brazil has a Unified Health System (SUS), a single-payer public health network that provides free medical services to all Brazilians.
About 95% of transplants in the country are managed by the SUS. According to the Health Ministry, Brazil has the second-highest number of transplant procedures in the world, followed by the U.S. Moreover, medical tourism in the country is among the fastest-growing medical treatment hotspots for international patients seeking affordable treatment.
Intensive research carried by the organizations to reduce organ transplant waiting time is expected to propel the country’s transplantation market. In February 2019, the University of São Paulo's Biosciences Institute (IB-USP) and the Human Genome and Stem-Cell Research Center (HUG-CELL) initiated the cross-species transplantation project.
Horizon Databook provides a detailed overview of country-level data and insights on the Brazil artificial organs and bionics market, including forecasts for subscribers. This country databook contains high-level insights into Brazil artificial organs and bionics market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account